Lawrence Livermore National Laboratory (LLNL) reports that its technology transfer team has opened up multiple fronts to aid the nation’s efforts against the virus that causes COVID-19.
One Bay Area company has developed a test to detect SARS-CoV-2 based on an LLNL technology, while a second Bay Area firm that has licensed an LLNL technology has gained approval for a product to diagnose SARS-CoV-2. In addition, the office of the LLNL Deputy Director for Science and Technology has invested more than $1 million to develop a prototype ventilator and other technologies.
Click here to learn more.
